Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
How pandemic-driven talent migration will change where biotech companies are located
Joel Marcus ' fortunes have risen with those of the life sciences industry. The executive chairman of life sciences builder Alexandria Real Estate Equities first bought laboratory space in Seattle in 1996, two years after founding the company when…
Licensing biotech breakthroughs is a mess. Can it be fixed?
Students, employees, and professors at a research institution generally pledge that in the event they make some interesting, potentially money-making discovery, they'll notify their institution's tech transfer office. This office can go by many…
Rewriting the Genome for Health: From Bench to Biotech
Dr. Kathiresan will discuss his journey from being a professor and cardiologist at Harvard Medical School to becoming the co-founder and chief executive officer of Verve Therapeutics. He will discuss leading Verve through its promising preclinical…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/N4FYHBNODBJNPOPHT3OC5FWJCE.jpg)
Review of India's Covaxin shot underway, WHO says
GENEVA, Oct 26 (Reuters) - A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said. 'If all is in…
WSJ News Exclusive | State Department to Form New Cyber Office to Face Proliferating Global Challenges
WASHINGTON—The State Department is planning to roll out organizational changes intended to confront international cybersecurity challenges like ransomware and waning global digital freedom, U.S. officials said, the latest of several…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/A3HINTCFCVOKPGLGXNZCETZPJE.jpg)
Freshfields adds Arnold & Porter duo in latest life sciences push
Both have worked with AstraZeneca, also a Freshfields client The company and law firm names shown above are generated automatically based on the text of the article. We are improving this feature as we continue to test and develop in beta. We…
A transatlantic biotech flags a painful PhIII cancer flop, waving a white flag
More than 4 years after little Erytech inflated some rare passion for its stock with upbeat Phase IIb data for their lead drug in pancreatic cancer, they've let the air out of the…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HTWXOQKULNKVPDQQM6TYDHVUJE.jpg)
Vaccinated but stuck: Indians await WHO nod for homegrown shot to travel abroad
PANDALAM, India, Oct 26 (Reuters) - Stuck in a village in southern India for nine months and unable to return to his job in Saudi Arabia, Sugathan P.R. is hoping the World Health Organization will approve the Indian COVID-19 shot Covaxin, paving…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IE22OFLXBRLWZFPBRQMDYEXZVE.jpg)
S.Korea's GL Rapha certified to produce Sputnik COVID-19 vaccines
MOSCOW, Oct 26 (Reuters) - South Korean biotech firm GL Rapha has secured regulatory approval from Russia to produce and market the Sputnik family of coronavirus vaccines, the company and Russian sovereign fund RDIF said on Tuesday. The…
WHO Clears HPV Shot from China's Innovax to Ease Global Shortage
New shot from China will ease shortage from western makers WHO approval opens up international market for Chinese maker The World Health Organization approved a cervical cancer vaccine from China's Beijing Wantai Biological Pharmacy Enterprise Co.…
Founded last year, Mozart Therapeutics lands $55M to develop therapies for celiac and other diseases
A year and a few months since its founding, Mozart Therapeutics has secured $55 million to develop therapies for celiac disease and other immune-related conditions, the company announced Tuesday. The Seattle-based biotech startup is developing…
Vir Biotechnology (NASDAQ:VIR) Upgraded by JPMorgan Chase & Co. to 'Neutral'
JPMorgan Chase & Co. upgraded shares of Vir Biotechnology (NASDAQ:VIR) from an underweight rating to a neutral rating in a research note published on Monday morning, Price Targets.com reports. JPMorgan Chase & Co. currently has $37.00 price…
Nvidia's GTC will draw 200K researchers for online event including metaverse session
Join gaming leaders online at GamesBeat Summit Next this upcoming November 9-10. Learn more about what comes next. The metaverse may be the stuff of science fiction, but it's going to make an appearance at a pretty serious tech event: Nvidia's…
Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Sold by California Public Employees Retirement System
California Public Employees Retirement System lowered its stake in Vir Biotechnology, Inc. (NASDAQ:VIR) by 6.6% during the second quarter, Holdings Channel.com reports. The firm owned 132,556 shares of the company's stock after selling 9,376 shares…
Mark Cuban and an employer's coalition to launch new PBMs
As Americans grapple with prescription drug costs, two new companies are being launched in hopes of transforming the opaque pharmaceutical supply chain that bedevils employers. The Mark Cuban Cost Plus Drug Company and the Purchaser Business Group…
Receive a Daily briefing on Biotech Industry News
Learn from targeted reports
Our focused News Briefs help you stay up-to-date with any and all of your industry interests